• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

隐静脉冠状动脉旁路移植术中血栓形成、破裂的动脉粥样硬化斑块:十年经验

Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years' experience.

作者信息

Walts A E, Fishbein M C, Matloff J M

机构信息

Division of Anatomic Pathology, Cedars-Sinai Medical Center, Los Angeles, CA 90048.

出版信息

Am Heart J. 1987 Oct;114(4 Pt 1):718-23. doi: 10.1016/0002-8703(87)90780-0.

DOI:10.1016/0002-8703(87)90780-0
PMID:3499063
Abstract

During the past decade the number of patients undergoing saphenous vein coronary artery bypass grafting (CABG) has increased worldwide. With a rate of late graft occlusion approximating 4% each year, the number of patients at risk for late graft occlusion continues to increase. Whereas in 1976 only 0.8% of the CABGs performed at our institution were reoperations for occluded grafts, by 1985 repeat procedures comprised 12.4% of the CABGs performed. Excised, occluded saphenous vein grafts from 52 of 119 (44%) of these patients showed thrombosis superimposed on ruptured atheromatous plaques. Ten autopsy patients showed similar lesions in their occluded grafts. The lesion was present in grafts excised as early as 3 years and as late as 14 years after bypass surgery; most occurred 5 to 10 years after implantation. Neither age at first bypass, sex, nor coronary artery bypassed permitted prediction of the occurrence of the lesion. Thrombosed, ruptured atheromatous plaque is a common, clinically significant mechanism of late graft occlusion. It is associated with recurrent symptoms that necessitate repeat revascularization and may result in death. The lesion may also be amenable to thrombolytic therapy, angioplasty, or both.

摘要

在过去十年中,全球接受大隐静脉冠状动脉旁路移植术(CABG)的患者数量有所增加。由于移植血管晚期闭塞率每年约为4%,面临移植血管晚期闭塞风险的患者数量持续上升。1976年在我们机构进行的CABG手术中,因移植血管闭塞而进行再次手术的仅占0.8%,到1985年,再次手术的比例占所进行CABG手术的12.4%。在这些患者中,119例中有52例(44%)切除的闭塞大隐静脉移植血管显示血栓形成叠加在破裂的动脉粥样硬化斑块上。10例尸检患者的闭塞移植血管也有类似病变。该病变在旁路手术后3年至14年切除的移植血管中均有出现;大多数发生在植入后5至10年。首次旁路手术时的年龄、性别或所绕过的冠状动脉均无法预测该病变的发生。血栓形成、破裂的动脉粥样硬化斑块是移植血管晚期闭塞常见的、具有临床意义的机制。它与需要再次血运重建的复发症状相关,可能导致死亡。该病变也可能适用于溶栓治疗、血管成形术或两者结合。

相似文献

1
Thrombosed, ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: ten years' experience.隐静脉冠状动脉旁路移植术中血栓形成、破裂的动脉粥样硬化斑块:十年经验
Am Heart J. 1987 Oct;114(4 Pt 1):718-23. doi: 10.1016/0002-8703(87)90780-0.
2
Ruptured atheromatous plaques in saphenous vein coronary artery bypass grafts: a mechanism of acute, thrombotic, late graft occlusion.大隐静脉冠状动脉旁路移植术中动脉粥样硬化斑块破裂:急性、血栓形成性、晚期移植物闭塞的一种机制
Circulation. 1982 Jan;65(1):197-201. doi: 10.1161/01.cir.65.1.197.
3
The severity of atherosclerosis at sites of plaque rupture with occlusive thrombosis in saphenous vein coronary artery bypass grafts.大隐静脉冠状动脉旁路移植术中伴有闭塞性血栓形成的斑块破裂部位的动脉粥样硬化严重程度。
Am Heart J. 1991 Oct;122(4 Pt 1):955-8. doi: 10.1016/0002-8703(91)90457-s.
4
The pathology of surgically excised aortocoronary saphenous vein bypass grafts.
Am J Surg Pathol. 1981 Jul;5(5):491-6. doi: 10.1097/00000478-198107000-00008.
5
Clinical and angiographic results of transluminal extraction coronary atherectomy in saphenous vein bypass grafts.隐静脉搭桥术中腔内抽吸取栓冠状动脉斑块旋切术的临床及血管造影结果
Circulation. 1994 Jan;89(1):302-12. doi: 10.1161/01.cir.89.1.302.
6
Late thrombosis of saphenous vein coronary bypass grafts related to risk factors.与危险因素相关的大隐静脉冠状动脉旁路移植血管晚期血栓形成
Circulation. 1988 Sep;78(3 Pt 2):I140-3.
7
Management during reoperation of aortocoronary saphenous vein grafts with minimal atherosclerosis by angiography.
Ann Thorac Surg. 1986 Aug;42(2):163-7. doi: 10.1016/s0003-4975(10)60511-5.
8
[Histological study of saphenous vein graft disease after coronary artery bypass grafting].冠状动脉旁路移植术后大隐静脉移植血管病变的组织学研究
Nihon Kyobu Geka Gakkai Zasshi. 1993 Apr;41(4):592-7.
9
Morphology of saphenous vein-coronary artery bypass grafts: Seven to 116 months after surgery.大隐静脉-冠状动脉旁路移植血管的形态学:术后7至116个月
Arch Pathol Lab Med. 1983 Jan;107(1):13-8.
10
Morphologic changes in long-term saphenous vein bypass grafts.
Chest. 1985 Sep;88(3):341-8. doi: 10.1378/chest.88.3.341.

引用本文的文献

1
Bypass Grafting and Native Coronary Artery Disease Activity.旁路移植术与原生冠状动脉疾病活动。
JACC Cardiovasc Imaging. 2022 May;15(5):875-887. doi: 10.1016/j.jcmg.2021.11.030. Epub 2022 Feb 16.
2
The Role of Immunomodulation in Vein Graft Remodeling and Failure.免疫调节在静脉移植物重塑和失败中的作用。
J Cardiovasc Transl Res. 2021 Feb;14(1):100-109. doi: 10.1007/s12265-020-10001-y. Epub 2020 Jun 16.
3
TGFβ, smooth muscle cells and coronary artery disease: a review.TGFβ、平滑肌细胞与冠状动脉疾病:综述
Cell Signal. 2019 Jan;53:90-101. doi: 10.1016/j.cellsig.2018.09.004. Epub 2018 Sep 15.
4
Mechanotransduction in Coronary Vein Graft Disease.冠状动脉旁路移植血管病变中的机械转导
Front Cardiovasc Med. 2018 Mar 14;5:20. doi: 10.3389/fcvm.2018.00020. eCollection 2018.
5
Inflammation in Vein Graft Disease.静脉移植物疾病中的炎症
Front Cardiovasc Med. 2018 Jan 24;5:3. doi: 10.3389/fcvm.2018.00003. eCollection 2018.
6
Role of smooth muscle cells in coronary artery bypass grafting failure.平滑肌细胞在冠状动脉旁路移植术失败中的作用。
Cardiovasc Res. 2018 Mar 15;114(4):601-610. doi: 10.1093/cvr/cvy021.
7
Linking gene dynamics to vascular hyperplasia - Toward a predictive model of vein graft adaptation.将基因动力学与血管增生相联系——迈向静脉移植物适应性的预测模型。
PLoS One. 2017 Nov 30;12(11):e0187606. doi: 10.1371/journal.pone.0187606. eCollection 2017.
8
Vein graft failure: from pathophysiology to clinical outcomes.静脉移植物失败:从病理生理学到临床结局。
Nat Rev Cardiol. 2016 Aug;13(8):451-70. doi: 10.1038/nrcardio.2016.76. Epub 2016 May 19.
9
Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis.原位冠状动脉、静脉移植物和支架内动脉粥样硬化的病理生理学。
Nat Rev Cardiol. 2016 Feb;13(2):79-98. doi: 10.1038/nrcardio.2015.164. Epub 2015 Oct 27.
10
Alternative blood conduits: assessment of whether the porosity of synthetic prostheses is the key to long-term biofunctionality.替代血液管道:评估合成假体的孔隙率是否是长期生物功能的关键。
Med Biol Eng Comput. 2000 Mar;38(2):219-25. doi: 10.1007/BF02344780.